Effects of Kanglaite on cachexia and immune function of the patients with advanced cancer.
康莱特对晚期恶性肿瘤患者恶病质和免疫功能的影响。
Objective To study and evaluate the effects of Kanglaite Injection (KLT) in rat model of cancer pain.
目的利用癌症痛动物模型，研究和评价康莱特注射液治疗癌症疼痛的疗效。
Objective: To screen the differential expression genes of Kanglaite Injection in treating cancer cachexia.
目的：寻找中药康莱特抗癌症恶病质的表达差异基因。
Conclusions: Kanglaite Injection can inhibit tumor angiopoiesis, its mechanism and regulate related to VEGF/VEGFR-2 signal conduct.
结论：康莱特能在一定程度上抑制肿瘤血管生成，其作用机制与调控VEGF／VEGFR-2信号传导有关。
Conclusion ATRA and Kanglaite injection can reverse precancerous squamous epithelial lesions in rabbits and may be used as new intervention chemicals.
结论全反式维甲酸和康莱特注射液可逆转家兔颊黏膜鳞状上皮癌前病变，有可能成为新的化学阻断干预药物。
CONCLUSION: Kanglaite combined with Gemzar could inhibit the growth of the transplanted human pancreatic carcinoma in nude mice and has synergistic effect.
结论：康莱特注射液与健择对移植于裸鼠的人胰腺癌的抑制作用具有协同效应。
Conclusions: Kanglaite injection combined with chemical medicine through artery infusion has relatively better curative effects on hepatic metastasis carcinoma.
结论：康莱特联合化学药物动脉灌注治疗转移性肝癌有较好的疗效。
Objective it is to discuss the clinical significance of Kanglaite injection combined with chemotherapy on life quality improved in non-small cell lung cancer (NSCLC) patients in advanced stage.
目的探讨康莱特注射液联合化疗对晚期非小细胞肺癌(NSCLC)患者生活质量改善的临床意义。
Objective it is to discuss the clinical significance of Kanglaite injection combined with chemotherapy on life quality improved in non-small cell lung cancer (NSCLC) patients in advanced stage.
目的探讨康莱特注射液联合化疗对晚期非小细胞肺癌(NSCLC)患者生活质量改善的临床意义。
应用推荐